As Bristol Myers Squibb Co (BMY) Shares Rose, Wellington Management Group Llp Increased Its Stake

May 17, 2018 - By Robert Reynolds

Bristol-Myers Squibb Company (NYSE:BMY) Corporate LogoDuring 2017 Q4 the big money sentiment decreased to 0.94. That’s change of 0.09, from 2017Q3’s 1.03. 72 investors sold all, 526 reduced holdings as BMY ratio dropped. 457 increased stakes while 106 funds bought stakes. Funds hold 1.11 billion shares thus 0.48% more from 2017Q3’s 1.11 billion shares. Plancorp Ltd Company owns 5,783 shs or 0.12% of their US capital. Truenorth stated it has 4,528 shs or 0.12% of all its holdings. 122,200 are held by Virginia Retirement Sys Et Al. Garrison Bradford Assoc has invested 0.2% in Bristol-Myers Squibb Company (NYSE:BMY). North Amer Mgmt reported 10,400 shs stake. Banque Pictet And Cie invested in 0.01% or 11,500 shs. 57,109 are owned by Optimum Investment Advisors. Old Natl Bancorp In holds 86,839 shs or 0.27% of its capital. Moreover, First Quadrant Ltd Partnership Ca has 0.02% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 18,663 shs. Putnam Fl Inv Mgmt Co reported 28,467 shs. Rock Springs Mgmt Ltd Partnership accumulated 50,000 shs or 0.14% of the stock. Clear Harbor Asset Mngmt Limited Liability accumulated 7,737 shs. Bkd Wealth Ltd Limited Liability Company, Missouri-based fund reported 14,530 shs. Chesapeake Asset Mgmt Limited Liability Co holds 0.23% or 3,971 shs in its capital. Legacy Capital Partners Incorporated holds 0.33% or 10,743 shs.

BMY had 1 sale and 2 buys since December 12, 2017. This’s net activity of $163,963. On Tuesday, December 12 Shares for $335,172 were sold by Lynch Thomas J. Jr.. Another trade for 4,000 shs valued at $249,187 was bought by Samuels Theodore R. II.

The stake In Bristol Myers Squibb Co (BMY) was increased held by Wellington Management Group Llp. According to 2017Q4 SEC form the decrease is 5762516.82%. 138.07 million shares were bought by Wellington Management Group Llp as the company’s stock rose 2.38% while stock markets declined. At the end of 2017Q4, the institutional investor held 138.07 million shares of the major pharmaceuticals company, priced at $8.46B, up from 2,396 at the end of the previous reported quarter. $85.36B is Bristol Myers Squibb Co’s market cap. BMY is touching $52.21 during the last trading session, after decreased 0.17%.Currently Bristol-Myers Squibb Company is uptrending after 11.37% change in last May 17, 2017. BMY has also 5.42M shares volume. The stock underperformed the S&P 500 by 0.18%.

About $452.59B US Long portfolio Wellington Management Group Llp manages. It decreased its stake in Mcbc Hldgs Inc by 1.04M shares to 583,717 shares, valued at $12.97 million in 2017Q4, according to the filing. For a total of 26.24 million shares it reduced its holding in Philip Morris Intl Inc (NYSE:PM) by 955,942 shares in the quarter, and has cut its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY).

For more Bristol-Myers Squibb Company (NYSE:BMY) news brought out recently go to:,,, or The titles are as follows: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” brought out on May 01, 2018, “Why Bristol-Myers Squibb Stock Crashed in April” on May 09, 2018, “Bristol-Myers Squibb (BMY) Highlights Breadth of Immuno-Oncology–Based Combination Research and Commitment …” with a publish date: May 16, 2018, “Ziopharm, Trump’s Drug Pricing Plan And The Future Of Expensive Drug Development” and the last “Don’t Buy L Brands – Cramer’s Lightning Round (5/15/18)” with publication date: May 16, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Ratings Coverage

In total 11 analysts cover Bristol Myers (NYSE:BMY). “Buy” rating has 4, “Sell” are 0, while 7 are “Hold”. (NYSE:BMY) has 36% bullish analysts. With $78.0 highest and $47 lowest target price, Bristol Myers has $65.56 average target price or 25.57% above the current ($52.21) price. 17 are the (NYSE:BMY)’s ratings reports on 17 May 2018 according to StockzIntelligence Inc. On Friday, April 27 the company was upgraded by BMO Capital Markets. On Friday, March 23 the firm earned “Hold” rating by Jefferies. On Tuesday, February 6 Leerink Swann maintained Bristol-Myers Squibb Company (NYSE:BMY) rating. Leerink Swann has “Buy” rating and $76.0 target. On Monday, February 26 the firm has “Hold” rating given by Jefferies. On Tuesday, April 17 the stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Equal-Weight” rating given by Morgan Stanley. On Monday, March 5 the firm has “Neutral” rating by Bank of America given. The stock rating was maintained by Bank of America with “Neutral” on Tuesday, April 17. On Wednesday, April 18 the rating was maintained by BMO Capital Markets with “Underperform”. On Wednesday, February 28 the stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by DZ Bank. The stock rating was upgraded by Morgan Stanley to “Overweight” on Thursday, February 15.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: